Ever Source Wealth Advisors, LLC Tango Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $2.2 Billion
- Q3 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 26,653 shares of TNGX stock, worth $217,755. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,653
Previous 26,631
0.08%
Holding current value
$217,755
Previous $136,000
63.97%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TNGX
# of Institutions
147Shares Held
130MCall Options Held
170KPut Options Held
17.6K-
Trv Gp Iv, LLC Boston, MA13.9MShares$113 Million100.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10.8MShares$87.9 Million0.39% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$86.9 Million6.71% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA8.54MShares$69.7 Million8.04% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$49.3 Million0.26% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $720M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...